// App-Quantinova.ai

BSH2020‐EP‐020 : Single hospital retrospective review of patients in treatment‐free remission (TFR) following therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukaemia (CML)

Researchers

Presenter

  • S. Kundu

Principal Investigators

  • H. Grubb

Medical Centers

  • Oncology, Withybush General Hospital, Haverfordwest, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Myelogenous Leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved